Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Permianville Royalty Trust Unit | PVL | Oct 10, 2024 | 1.58 | -0.63 |
PermRock Royalty Trust Unit | PRT | Oct 10, 2024 | 3.91 | +0.26 |
Perpetua Resources | PPTA | Oct 10, 2024 | 9.36 | +4.41 |
Perrigo | PRGO | Oct 10, 2024 | 24.25 | -0.86 |
Personalis | PSNL | Oct 10, 2024 | 4.94 | -2.18 |
Perspective Therapeutics | CATX | Oct 10, 2024 | 13.25 | +0.61 |
Petco Health And Wellness | WOOF | Oct 10, 2024 | 5.08 | -5.40 |
PetIQ A | PETQ | Oct 10, 2024 | 30.89 | +0.10 |
PetMed Express | PETS | Oct 10, 2024 | 3.86 | -3.02 |
Petroleo Brasileiro S.A.- Petrobras ADR | PBR | Oct 10, 2024 | 14.88 | -0.20 |
Petroleo Brasileiro S.A.- Petrobras ADR Pref | PBR-A | Oct 10, 2024 | 13.50 | +1.28 |
Petros Pharmaceuticals | PTPI | Oct 10, 2024 | 0.33 | +5.31 |
Pfizer | PFE | Oct 10, 2024 | 29.34 | -2.82 |
Pgim Global High Yield Fund | GHY | Oct 10, 2024 | 12.78 | -0.54 |
Pgim High Yield Bond Fund | ISD | Oct 10, 2024 | 13.91 | -1.42 |
PGIM Short Duration High Yield Opportunities Fund | SDHY | Oct 10, 2024 | 16.64 | -0.48 |
Pharmaceutical ETF Market Vectors | PPH | Oct 10, 2024 | 93.78 | -0.58 |
PharmaCyte Biotech | PMCB | Oct 10, 2024 | 1.73 | -1.14 |
Pharming Group ADR | PHAR | Oct 10, 2024 | 8.78 | +1.50 |
Pharvaris | PHVS | Oct 10, 2024 | 17.83 | -0.45 |
Phathom Pharmaceuticals | PHAT | Oct 10, 2024 | 15.71 | -0.25 |
PhenixFIN | PFX | Oct 10, 2024 | 47.82 | -0.10 |
Pheton | PTHL | Oct 10, 2024 | 5.03 | 0.00 |
Phibro Animal Health A | PAHC | Oct 10, 2024 | 22.89 | +3.20 |
Philip Morris | PM | Oct 10, 2024 | 119.39 | -0.66 |
Philippines Invstb Mkt Idx MSCI Ishares | EPHE | Oct 10, 2024 | 28.71 | -3.17 |
Phillips 66 | PSX | Oct 10, 2024 | 136.42 | +3.09 |
Phillips Edison & Company | PECO | Oct 10, 2024 | 35.95 | -0.75 |
PHINIA | PHIN | Oct 10, 2024 | 44.80 | +0.58 |
Phio Pharmaceuticals | PHIO | Oct 10, 2024 | 2.55 | -11.76 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.